PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Return
49.21%
This Quarter Return
+13.64%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$76.1M
AUM Growth
+$12.2M
(+19%)
Cap. Flow
+$1.69M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
28.24%
Holding
127
New
34
Increased
22
Reduced
26
Closed
28
Top Buys
| 1 |
Liberty Global Class A
LBTYA
|
+$2.32M |
| 2 |
Marvell Technology
MRVL
|
+$2.05M |
| 3 |
CSC
Computer Sciences
CSC
|
+$2.05M |
| 4 |
Universal Health Services
UHS
|
+$1.85M |
| 5 |
Alibaba
BABA
|
+$1.83M |
Top Sells
| 1 |
Range Resources
RRC
|
+$1.82M |
| 2 |
Cigna
CI
|
+$1.69M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.34M |
| 4 |
Salesforce
CRM
|
+$1.33M |
| 5 |
Biogen
BIIB
|
+$1.25M |
Sector Composition
| 1 | Healthcare | 41.37% |
| 2 | Technology | 11.69% |
| 3 | Communication Services | 6.82% |
| 4 | Energy | 5.01% |
| 5 | Consumer Discretionary | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Marvell Technology
MRVL
$58.1B
| $2.71M | 3.3% |
177,687
+134,466
| +311% | +$2.05M |
|
|
2
Liberty Global Class A
LBTYA
$4.05B
| $2.32M | 2.83% |
+64,720
| New | +$2.32M |
|
3
Jazz Pharmaceuticals
JAZZ
$7.65B
| $2.3M | 2.8% |
15,857
-2,489
| -14% | -$361K |
|
|
4
Biogen
BIIB
$21.2B
| $2.29M | 2.78% |
8,363
-4,570
| -35% | -$1.25M |
|
|
WFT
5
DELISTED
Weatherford International plc
WFT
| $2.13M | 2.59% |
320,408
+153,850
| +92% | +$1.02M |
|
|
CSC
6
DELISTED
Computer Sciences
CSC
| $2.05M | 2.5% |
+29,718
| New | +$2.05M |
|
7
BioMarin Pharmaceuticals
BMRN
$10.4B
| $1.93M | 2.35% |
21,964
-2,510
| -10% | -$220K |
|
8
Humana
HUM
$33.2B
| $1.92M | 2.34% |
9,315
+487
| +6% | +$100K |
|
|
MDCO
9
DELISTED
Medicines Co
MDCO
| $1.89M | 2.3% |
38,703
-22,851
| -37% | -$1.12M |
|
|
10
Universal Health Services
UHS
$12.2B
| $1.85M | 2.25% |
+14,847
| New | +$1.85M |
|
|
11
Alibaba
BABA
$370B
| $1.83M | 2.23% |
+16,967
| New | +$1.83M |
|
12
Elevance Health
ELV
$70.2B
| $1.76M | 2.14% |
10,637
-2,825
| -21% | -$467K |
|
13
Starbucks
SBUX
$93.1B
| $1.62M | 1.98% |
+27,820
| New | +$1.62M |
|
14
Pacira BioSciences
PCRX
$1.22B
| $1.56M | 1.9% |
34,213
+7,523
| +28% | +$343K |
|
15
Baxter International
BAX
$12.3B
| $1.46M | 1.77% |
+28,085
| New | +$1.46M |
|
16
GoDaddy
GDDY
$20.1B
| $1.41M | 1.72% |
37,287
+31,225
| +515% | +$1.18M |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.39M | 1.69% |
21,837
-3,772
| -15% | -$240K |
|
|
PTLA
18
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.39M | 1.69% |
35,362
+20,890
| +144% | +$819K |
|
|
SLCA
19
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.36M | 1.65% |
28,304
+10,203
| +56% | +$490K |
|
20
UnitedHealth
UNH
$319B
| $1.24M | 1.51% |
7,573
-5,472
| -42% | -$897K |
|
|
AERI
21
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.24M | 1.51% |
27,289
-4,557
| -14% | -$207K |
|
22
Eli Lilly
LLY
$677B
| $1.17M | 1.42% |
+13,895
| New | +$1.17M |
|
|
TFCFA
23
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $1.13M | 1.37% |
+34,857
| New | +$1.13M |
|
|
KITE
24
DELISTED
Kite Pharma, Inc.
KITE
| $1.06M | 1.29% |
13,513
-3,150
| -19% | -$247K |
|
|
25
Cigna
CI
$80.8B
| $1.04M | 1.27% |
7,119
-11,511
| -62% | -$1.69M |
|